MULTI-YEAR DYNAMICS OF SPREAD OF HEPATITIS C VIRUS GENOTYPES IN MOSCOW REGION
- Authors: Isaeva O.V.1, Kichatova V.S.1, Karlsen A.A.1, Solonin S.A.1,2, Dmitriev P.N.1, Kyuregyan K.K.1, Mikhailov M.I.1
-
Affiliations:
- Chumakov Institute of Poliomyelitis and Viral Encephalites
- Sklifosovksy Research Institute of Emergency Aid
- Issue: Vol 93, No 4 (2016)
- Pages: 35-42
- Section: ORIGINAL RESEARCHES
- Submitted: 10.04.2019
- Published: 28.08.2016
- URL: https://microbiol.crie.ru/jour/article/view/67
- DOI: https://doi.org/10.36233/0372-9311-2016-4-35-42
- ID: 67
Cite item
Full Text
Abstract
Keywords
About the authors
O. V. Isaeva
Chumakov Institute of Poliomyelitis and Viral Encephalites
Author for correspondence.
Email: noemail@neicon.ru
Россия
V. S. Kichatova
Chumakov Institute of Poliomyelitis and Viral Encephalites
Email: noemail@neicon.ru
Россия
A. A. Karlsen
Chumakov Institute of Poliomyelitis and Viral Encephalites
Email: noemail@neicon.ru
Россия
S. A. Solonin
Chumakov Institute of Poliomyelitis and Viral Encephalites; Sklifosovksy Research Institute of Emergency Aid
Email: noemail@neicon.ru
Россия
P. N. Dmitriev
Chumakov Institute of Poliomyelitis and Viral Encephalites
Email: noemail@neicon.ru
Россия
K. K. Kyuregyan
Chumakov Institute of Poliomyelitis and Viral Encephalites
Email: noemail@neicon.ru
Россия
M. I. Mikhailov
Chumakov Institute of Poliomyelitis and Viral Encephalites
Email: noemail@neicon.ru
Россия
References
- Антонова Т. В. и др. В: Онищенко Г. Г., Жебрун А. Б. (ред.). Вирусные гепатиты в РФ 2010. М3 РФ, Роспотребнадзор, Спб НИИЭМ им. Пастера, СПб, 2010.
- Кюрегян К.К., Михайлов М.И. Молекулярно-биологические основы контроля вирусных гепатитов. М., Икар, 2013.
- Калинина О.В. Молекулярно-генетические механизмы эволюции вируса гепатита С. Автореф. дисс. д.б.н. СПб, 2013.
- Шахгильдян И. В., Михайлов М. И., Онищенко Г. Г. Парентеральные вирусные гепатиты (эпидемиология, диагностика, профилактика). М., ГОУ ВУНМЦ М3 РФ, 2003.
- Demetriou V.L., Kyriakou Е., Kostrikis L.G. Near-full genome characterisation of two natural intergenotypic 2k/lb recombinant hepatitis C virus isolates. Adv. Virol. 2011, 2011: 710438.
- Esteban J.I., Sauleda S., Quer J. The changing epidemiology of hepatitis C vims infection in Europe. J. Hepatol. 2008, 48: 148-162.
- Hope V.D., Eramova I., Capurro D., Donoghoe M.C. Prevalence and estimation of hepatitis В and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol. Infect. 2014, 142:270-286.
- Kurbanov E, Tanaka Y., Chub E. et al. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RFl_2k/lb. J. Infect. Dis. 2008, 15, 198 (10): 1448-1456.
- Kalinina O., Norder H., Vetrov T. et al. Shift in predominating subtype of HCV from lb to 3a in St. Petersburg mediated by increase in injecting drug use. J. Med. Virol. 2001, 65: 517-524.
- Lidman C., Norden L., Kaberg M. et al. Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender. Scand. J. Infect. Dis. 2009, 41: 679-684.
- Morice Y., Cantaloube J.F., Beaucourt S. et al. Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J. Med. Virol. 2006, 78 (10): 1296-1303.
- Miihlberger N., Schwarzer R., Lettmeier B. et al. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health. 2009, 9: 34.
- Nelson P.K., Mathers B.M., Cowie B. et al. Global epidemiology of hepatitis В and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011, 378: 571-583.
- Ohno T, Mizokami M. Genotyping with type-specific primers that can type HCV types 1-6. Methods in molecular medicine, Vol. 19: Hepatitis C protocols. 1998, p: 159-164.
- Pybus O.G., Cochrane A., Holmes E.C., Simmonds P. The hepatitis C virus epidemic among injecting drug users. Infect. Genet. Evol. 2005, 5 (2): 131-139.
- Rhodes T, Platt L., Maximova S. et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction. 2006, 101: 252-266.
- Sama A., Panda S. HCV in people who inject drugs: a neglected epidemic. Lancet Infect. Dis. 2015,15:4-5.
- Simmonds P. Genetic diversity and evolution of hepatitis C virus - 15 years on. J. Gen. Virol. 2004, 85 (11): 3173-3188.
- Thorpe L. E., Ouellet L. J., Hershow R. et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am. J. Epidemiol. 2002, 155: 645-653.
- World Health Organization. A strategy to halt and reverse the HIV epidemic among people who inject drugs in Asia and the Pacific: 2010 - 2015, WHO Library Cataloguing, 2015.